Citation Impact
Citing Papers
Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer
2003 Standout
Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance
2003 Standout
Computed Tomography — An Increasing Source of Radiation Exposure
2007 Standout
Hepatocellular carcinoma
2003 Standout
Testicular Germ-Cell Cancer
1997 Standout
Gadolinium‐labeled liposomes containing various amphiphilic Gd‐DTPA derivatives: Targeted MRI contrast enhancement agents for the liver
1991
Multifunctional magnetic nanoparticles for targeted imaging and therapy☆
2008
Molecular imaging in living subjects: seeing fundamental biological processes in a new light
2003 Standout
Metal–organic framework composites
2014 Standout
Ultrasmall superparamagnetic particles of iron oxide (USPIO) MR imaging of infarcted myocardium in pigs
1998
Gold nanoparticles: a new X-ray contrast agent
2006
Visceral abdominal-fat accumulation associated with use of indinavir
1998
Fine‐needle aspiration biopsy in children: Experience in 70 cases
1988
The β-Thalassemias
1999 Standout
Evaluation of iron overload
2004
Iron Overload Cardiomyopathy
2010
Limitations of Current Preoperative Liver Imaging Techniques for Intrahepatic Metastatic Nodules of Hepatocellular Carcinoma
1992
Phaeochromocytoma
2005 Standout
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
2008 Standout
Tissue-specific MR contrast agents
2003
Lipolysis in Intraabdorninal Adipose Tissues of Obese Women and Men
1993
Interventional MR: interstitial therapy
1999
Role of image-guided core-needle biopsy in the management of patients with lymphoma.
1996
Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.
1993 Standout
Estimation of deep abdominal adipose-tissue accumulation from simple anthropometric measurements in men
1991
Adipose Tissue Quantification by Imaging Methods: A Proposed Classification
2003
Diagnostic and Therapeutic Strategies
1987 Standout
Targeted ultrasonic contrast agents for molecular imaging and therapy
2001
Human Body Composition and the Epidemiology of Chronic Disease
1995
Statement on outpatient percutaneous liver biopsy
1989
CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma
2002 Standout
Gallium 67 imaging in monitoring lymphoma response to treatment
1988
Genetic and Clinical Features of Hemoglobin H Disease in Chinese Patients
2000
ACR Appropriateness Criteria® on Renal Failure
2014
Effects of body fat distribution on regional lipolysis in obesity.
1991
Management of Hepatocellular Carcinoma *
2005 Standout
Validation of an extension of the international non‐invasive criteria for the diagnosis of hepatocellular carcinoma to the characterization of macroscopic portal vein thrombosis
2010
Increased Blood Glucose and Insulin, Body Size, and Incident Colorectal Cancer
1999
Inflammatory Bowel Disease
1991 Standout
Diabetes in Asia
2009 Standout
Functional Studies of the Human Brain Using High‐speed Magnetic Resonance Imaging
1991
Applications of advanced hybrid organic–inorganic nanomaterials: from laboratory to market
2011 Standout
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
2004 Standout
A role of PIEZO1 in iron metabolism in mice and humans
2021 StandoutNobel
Interim [18F]fluorodeoxyglucose positron emission tomography imaging in stage I–II non-bulky Hodgkin lymphoma: would using combined positron emission tomography and computed tomography criteria better predict response than each test alone?
2012
Diagnostic efficacy and safety of MRI of the liver with superparamagnetic iron oxide particles (SH U 555 A)
2001
The golden age: gold nanoparticles for biomedicine
2011 Standout
Polycystic Ovary Syndrome
1995 Standout
Liver positive enhancement after injection of superparamagnetic nanoparticles: Respective role of circulating and uptaken particles
1997
Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis
1996 Standout
Frequency of inflammatory bowel disease in offspring of couples both presenting with inflammatory bowel disease
1991
Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: acohort study
1999 Standout
Waist-hip ratio is a poor predictor of changes in visceral fat
1993
Detection of Hepatocellular Carcinoma: Combined T2-Weighted and Dynamic Gadolinium-Enhanced MRI Versus Combined CT During Arterial Portography and CT Hepatic Arteriography
2001
The role of ultrasonography and automatic-needle biopsy in outpatient percutaneous liver biopsy
1996
Laparoscopic Approach to Colonic Cancer: Critical Appraisal of the Literature
2007
Elevated C-Reactive Protein Levels in Overweight and Obese Adults
1999 Standout
Phase I clinical evaluation of a new iron oxide MR contrast agent
1994
Contrast Agents for MR Imaging of the Liver
2001
Acute Pancreatitis
1994 Standout
Imaging strategies to reduce the risk of radiation in CT studies, including selective substitution with MRI
2007
Genetic and Nongenetic Determinants of Regional Fat Distribution
1993
Advances in functional and molecular MRI technologies in chronic liver diseases
2020
Visceral obesity and breast cancer risk
1994
Evaluation of lymph nodes with RECIST 1.1
2008
Magnetic Nanoparticles: Synthesis, Protection, Functionalization, and Application
2007 Standout
Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: recommendations for patient selection.
1990
Liver Biopsy
2001 Standout
Chronic Kidney Disease
2016 Standout
Sex-specific Associations of Magnetic Resonance Imaging-derived Intra-abdominal and Subcutaneous Fat Areas with Conventional Anthropometric Indices: The Atherosclerosis Risk in Communities Study
1996
Current Standards of Care in Small-Cell and Non-Small-Cell Lung Cancer
2001
Role of magnetic resonance imaging in predicting relapse in residual masses after treatment of lymphoma.
1993
Image-guided core-needle biopsy in malignant lymphoma: experience with 100 patients that suggests the technique is reliable.
1996
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications
1999 Standout
Revised Response Criteria for Malignant Lymphoma
2007 Standout
Magnetic Iron Oxide Nanoparticles: Synthesis, Stabilization, Vectorization, Physicochemical Characterizations, and Biological Applications
2008 Standout
Overview of transition metal and lanthanide complexes as diagnostic tools
1999
Contribution of Abdominal Adiposity to Age-Related Differences in Insulin Sensitivity and Plasma Lipids in Healthy Nonobese Women
2001
Size-Controlled Synthesis of Magnetite Nanoparticles
2002 Standout
Ultrasound Microbubble Contrast Agents: Fundamentals and Application to Gene and Drug Delivery
2006 Standout
Visceral Fat Accumulation as a Risk Factor for Prostate Cancer
2004
Monodisperse MFe2O4 (M = Fe, Co, Mn) Nanoparticles
2003 Standout
18-FDG-PET for the assessment of residual masses on CT following treatment of lymphomas
2000
Delivery of diagnostic agents for magnetic resonance imaging
1999
Dynamic magnetic resonance imaging of human brain activity during primary sensory stimulation.
1992 Standout
Residual abdominal masses after chemotherapy for nonseminomatous testicular cancer: correlation of CT and histology
1985
Quantification of adipose tissue by MRI: relationship with anthropometric variables
1992
Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
2014 Standout
Ferroptosis as a target for protection against cardiomyopathy
2019 Standout
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
Residual tumor masses following treatment for advanced histiocytic lymphoma. Diagnostic and therapeutic implications
1985
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Treatment of Pyogenic Hepatic Abscesses
1986
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Recent Advances in the Synthesis and Application of Layered Double Hydroxide (LDH) Nanosheets
2012 Standout
Intrahepatic pyogenic abscesses: Treatment by percutaneous drainage
1985
Liver transplantation for hepatocellular carcinoma
1995
Iron-Chelating Therapy and the Treatment of Thalassemia
1997
Obesity: An important prognostic factor in acute pancreatitis
1993
Effectiveness of MR Imaging in Characterizing Small Hepatic Lesions: Routine Versus Expert Interpretation
2003
The Clinically Inapparent Adrenal Mass: Update in Diagnosis and Management
2004
Exceedingly small iron oxide nanoparticles as positive MRI contrast agents
2017 StandoutNobel
Magnetic nanoparticle design for medical diagnosis and therapy
2004 Standout
Prevalence of Childhood and Adult Obesity in the United States, 2011-2012
2014 Standout
Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas
1999 Standout
Fast detection of liver fibrosis with collagen-binding single-nanometer iron oxide nanoparticles via T 1 -weighted MRI
2023 StandoutNobel
Inorganic Nanoparticles for MRI Contrast Agents
2009 Standout
Works of Michael E. Bernardino being referenced
Hepatic iron overload: Diagnosis and quantification by noninvasive imaging
1990
Focal liver lesions: characterization with nonenhanced and dynamic contrast material-enhanced MR imaging.
1994
Liver transplant biopsies with a biopsy gun.
1991
Liver and abdominal screening in patients with cancer: CT versus MR imaging.
1988
Percutaneous renal and adrenal biopsies
1991
Perfluoroctyl bromide as a blood pool contrast agent for computed tomographic angiography
1994
Management of the asymptomatic patient with a unilateral adrenal mass.
1988
Hepatic MR imaging with Mn-DPDP: safety, image quality, and sensitivity.
1992
Enhancement effects of a hepatocyte receptor—specific MR contrast agent in an animal model
1994
Dual contrast enhancement of both T1- and T2-weighted sequences using ultrasmall superparamagnetic iron oxide
1993
Delayed Magnetic Resonance Hepatic Imaging with Gadolinium-DTPA
1988
Hepatic tumors: comparison of CT during arterial portography, delayed CT, and MR imaging for preoperative evaluation.
1989
Hepatocellular tumors: characterization with Mn-DPDP-enhanced MR imaging.
1993
Adrenal masses: characterization with T1-weighted MR imaging.
1988
Contrast-enhanced MR imaging of hepatic lesions treated with percutaneous ethanol ablation therapy.
1993
The frequency and significance of small (less than or equal to 15 mm) hepatic lesions detected by CT.
1992
Preoperative localization of focal liver lesions to specific liver segments: utility of CT during arterial portography.
1990
Hepatic metastases: CT versus MR imaging at 1.5T
1991
Imaging Guided Percutaneous Hepatic Biopsy: Diagnostic Accuracy and Safety
1985
Percutaneous Drainage of Multiseptated Hepatic Abscess
1984
Discrete colonic ulcers associated with oral contraceptives
1976
Percutaneous needle biopsy in the diagnosis and classification of lymphoma
1986
Abdominal composition quantified by computed tomography
1988
Incidence and Significance of Serendipitous CT Findings in the Oncologic Patient
1982
Magnetic resonance imaging of the liver
1990
Post-Therapy CT-Detected Mass in Lymphoma Patients
1982
Pitfalls of CT Findings in Post-Therapy Testicular Carcinoma
1981
The computed tomography-guided adrenal biopsy: An alternative to surgery in adrenal mass diagnosis
1984
Isolated adrenal masses in nonsmall-cell bronchogenic carcinoma.
1984